Sanofi isn’t saying how much it is paying for the OTC rights to Tamiflu in the US ... as Tamiflu continues to decline, with the older brand reduced to just $179m in the first quarter of this ...

Sanofi is closer ... a portfolio of 100 brands, including Allegra, Doliprane, Novanight, Icy Hot and Dulcolax, Opella is the world's third-largest company in the over-the-counter and vitamins ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

It accounts for around 13% of Sanofi's total revenues and is reported to be the world's third-largest company in the over-the-counter medicines ... with a portfolio of 100 brands.

The OTC Consumer Health Market report covers the Top Key Players. Johnson & Johnson, Abbott Laboratories, Sanofi, GlaxoSmithKline plc. Bayer AG, Nestle Company, Procter & Gamble Corp., Danone Food ...

Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).

A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...